Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:38 pm Purchase |
2020-12-31 | 13G | Quotient Limited QTNT |
PERCEPTIVE ADVISORS LLC | 405,020 16.000% |
72,794 (+21.91%) |
Filing History |
| 2021-02-16 3:38 pm Purchase |
2020-12-31 | 13G | UROVANT SCIENCES LTD SHS UROV |
PERCEPTIVE ADVISORS LLC | 3,116,831 9.800% |
709,900 (+29.49%) |
Filing History |
| 2021-02-16 3:38 pm Sale |
2020-12-31 | 13G | Kodiak Sciences Inc. KOD |
PERCEPTIVE ADVISORS LLC | 751,533 1.500% |
-2,912,024 (-79.49%) |
Filing History |
| 2021-02-16 3:38 pm Unchanged |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
PERCEPTIVE ADVISORS LLC | 608,544 5.400% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:37 pm Purchase |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 16,584,802 17.500% |
500,000 (+3.11%) |
Filing History |
| 2021-02-16 3:37 pm Purchase |
2020-12-31 | 13G | Zymeworks Inc. ZYME |
PERCEPTIVE ADVISORS LLC | 4,300,999 9.400% |
1,897,973 (+78.98%) |
Filing History |
| 2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 4,671,836 6.500% |
1,085,351 (+30.26%) |
Filing History |
| 2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 2,360,139 12.400% |
655,809 (+38.48%) |
Filing History |
| 2021-02-16 3:36 pm Unchanged |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
PERCEPTIVE ADVISORS LLC | 6,706,268 5.500% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:35 pm Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
PERCEPTIVE ADVISORS LLC | 5,674,711 9.200% |
-191,015 (-3.26%) |
Filing History |
| 2021-02-16 3:35 pm Purchase |
2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PERCEPTIVE ADVISORS LLC | 4,177,721 8.600% |
880,199 (+26.69%) |
Filing History |
| 2021-02-16 3:35 pm Unchanged |
2020-12-31 | 13G | BCLS Acquisition Corp. BLSA |
PERCEPTIVE ADVISORS LLC | 1,000,000 7.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:34 pm Purchase |
2020-12-31 | 13G | Athenex, Inc. ATNX |
PERCEPTIVE ADVISORS LLC | 676,623 14.500% |
100,000 (+17.34%) |
Filing History |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 9,166,304 6.300% |
-245,092 (-2.60%) |
Filing History |
| 2021-02-16 3:33 pm Unchanged |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
PERCEPTIVE ADVISORS LLC | 4,482,713 5.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Frequency Therapeutics, Inc. FREQ |
PERCEPTIVE ADVISORS LLC | 65,193 9.700% |
4,507 (+7.43%) |
Filing History |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Provention Bio, Inc. PRVB |
PERCEPTIVE ADVISORS LLC | 4,224,389 6.700% |
1,302,815 (+44.59%) |
Filing History |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 25,112,048 9.700% |
-20,316 (-0.08%) |
Filing History |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,703,879 19.100% |
2,418,421 (+38.48%) |
Filing History |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,577,481 6.400% |
250,000 (+18.83%) |
Filing History |